The collaboration will evaluate InVivo's biopolymer devices synergistically combined with cellular therapies, including The Miami Project's Schwann cell technologies.
Key components of the research collaboration agreement include in vitro and in vivo studies with combinations of biomaterials, Schwann cells and other cellular therapies and drugs; joint ownership of resulting intellectual property; and the right of first offer for InVivo to license and commercialize on a worldwide exclusive basis.
